ESMO 2022: Updates in Breast Cancer

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer.   In this podcast, we hear from some of the leading experts in breast cancer, as they discuss the biggest trials and hot topics from the meeting. Dr Elisa Agostinetto discusses three of the biggest trials for metastatic breast cancer: TROPiCS02 (NCT03901339), MONARCH 3 (NCT02246621) and SYNERGY (NCT03616886). Prof. Fabrice Andre talks on the monarcHER trial (NCT02675231) and Dr Naoto Ueno explains the patient-reported outcome data from the DESTINY-Breast04 trial (NCT03734029).